AFP and hepatocellular carcinoma: In addition to RASSF1A, two abnormally methylated genes (APC and COX2) and one miRNA (miR-203) were combined to establish a predictive model by which nearly 75% of HCC patients were detected, who could not be diagnosed with AFP [92].